Devil vaccine a step closer

Greg Woods and Bruce Lyons.

Greg Woods and Bruce Lyons.

The results of an international study published recently in Scientific Reports has confirmed the fatal facial tumour disease that has decimated populations of Tasmanian devils in the wild for over 20 years, can be cured using immunotherapy.

Led by the University of Tasmania’s Menzies Institute for Medical Research, the study involved scientists from the Universities of Sydney, Southampton, Southern Denmark and Cambridge, as well as those from UTAS’s School of Medicine, the Walter and Eliza Hall Institute of Medical Research, and CSL Ltd.

The aim of the study was to ‘explore immunisation protocols to enhance protective responses against DFTD’, but due to devils’ endangered status, only a limited number of animals are available for research purposes. This five-year trial, that tested four immunisation protocols sequentially, was therefore restricted to nine healthy and genetically different animals, some of which had reached an advanced age. Continue reading Devil vaccine a step closer